599
Views
4
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Survival of patients with CD20-negative variants of large B-cell lymphoma: an analysis of the National Cancer Data Base

ORCID Icon, ORCID Icon & ORCID Icon
Pages 1375-1383 | Received 27 Aug 2017, Accepted 22 Sep 2017, Published online: 11 Oct 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jorge J. Castillo, Brady E. Beltran, Luis Malpica, Mario L. Marques-Piubelli & Roberto N. Miranda. (2021) Anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK + LBCL): a systematic review of clinicopathological features and management. Leukemia & Lymphoma 62:12, pages 2845-2853.
Read now
Thomas A. Ollila, John L. Reagan & Adam J. Olszewski. (2019) Clinical features and survival of patients with T-cell/histiocyte-rich large B-cell lymphoma: analysis of the National Cancer Data Base. Leukemia & Lymphoma 60:14, pages 3426-3433.
Read now
Andres Lopez & Pau Abrisqueta. (2018) Plasmablastic lymphoma: current perspectives. Blood and Lymphatic Cancer: Targets and Therapy 8, pages 63-70.
Read now

Articles from other publishers (1)

Joel C. Wight, Geoffrey Chong, Andrew P. Grigg & Eliza A. Hawkes. (2018) Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI. Blood Reviews 32:5, pages 400-415.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.